ask="2.06"
ask_size="2000"
average_daily_volume="2158300"
bid="2.01"
bid_size="1900"
book_value="4.53"
change="-0.08"
change_from_200_day_moving_average="-0.66"
change_from_50_day_moving_average="-0.21"
change_from_52_week_high="-1.80"
change_From_52_week_low="0.11"
change_in_percent="-3.77%"
close="2.04"
dividend_pay_date="6/13/2016"
dividend_per_share="0.20"
dividend_yield="9.35"
earnings_per_share="1.06"
ebitda="244.51M"
eps_estimate_current_year="0.16"
eps_estimate_next_quarter="0.04"
eps_estimate_next_year="0.10"
ex_dividend_date="6/2/2016"
float_shares="150390000"
high="2.10"
high_52_weeks="3.84"
last_trade_date="3/2/2017"
last_trade_price="2.04"
last_trade_size="109291"
last_trade_time="4:00pm"
low="1.98"
low_52_weeks="1.93"
market_capitalization="337.70M"
moving_average_200_day="2.70"
moving_average_50_day="2.25"
name="PDL BioPharma
Inc."
notes="N/A"
one_year_target_price="3.50"
open="2.08"
pe_ratio="1.93"
peg_ratio="0.95"
percent_change_from_200_day_moving_average="-24.44%"
percent_change_from_50_day_moving_average="-9.42%"
percent_change_from_52_week_high="-46.88%"
percent_change_from_52_week_low="+5.70%"
previous_close="2.12"
price_eps_estimate_current_year="12.75"
price_eps_Estimate_next_year="20.40"
price_per_book="0.47"
price_per_sales="1.23"
revenue="286.16M"
shares_outstanding="165540000"
short_ratio="5.06"
stock_exchange="NMS"
symbol="PDLI"
volume="3027921"
weeks_range_52="1.93 - 3.84"
